7 months ago
BMRN
AnalystsMitchell S. KapoorMitchell S. Kapoor's Stock Forecasts
AnalystsMitchell S. Kapoor
Sectors:
Industries:
Analyst Ranking
Top 17%
#884 out of 5290 analysts
Average Return
+8.33%
Win Rate
45%49 out of 110
Risk vs Reward
Poor
Good
Mitchell S. Kapoor's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alumis IncALMS | +420.96% | $4.39 | $22.87 | 2025-08-13 - 2026-05-15 | Buy |
Oruka Therapeutics IncORKA | +275.08% | $15.25 | $57.20 | 2025-08-17 - 2026-06-03 | Buy |
Tyra Biosciences IncTYRA | +145.00% | $11.71 | $28.69 | 2025-08-21 - 2026-06-03 | Buy |
Kyverna Therapeutics IncKYTX | +110.78% | $3.71 | $7.82 | 2025-08-28 - 2026-06-03 | Buy |
Alumis IncALMS | +106.78% | $11.06 | $22.87 | 2025-12-17 - 2026-05-15 | Buy |
Mitchell S. Kapoor Analyst Color
Get additional color on Mitchell S. Kapoor's coverage of popular stocks
9 months ago
BMRN
Mitchell S. Kapoor's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kyverna Therapeutics IncKYTX | 5 | Buy | $25.00 | +219.69% | Reiterates | 2 days ago |
Legend Biotech CorpLEGN | 6 | Buy | $65.00 | +80.66% | Maintains | 2 days ago |
Lyell Immunopharma IncLYEL | 3 | Buy | $45.00 | +258.00% | Reiterates | 2 days ago |
Ionis Pharmaceuticals IncIONS | 9 | Buy | $125.00 | +69.33% | Reiterates | 4 days ago |
Evommune IncEVMN | 4 | Buy | $50.00 | +153.42% | Reiterates | 10 days ago |
Incyte CorpINCY | 8 | Buy | $135.00 | +37.78% | Reiterates | 15 days ago |
Korro Bio IncKRRO | 3 | Buy | $15.00 | +35.38% | Maintains | 17 days ago |
Biomarin Pharmaceutical IncBMRN | 7 | Hold | $50.00 | -8.53% | Maintains | 18 days ago |
Oruka Therapeutics IncORKA | 5 | Buy | $120.00 | +109.79% | Reiterates | 18 days ago |
Alumis IncALMS | 5 | Hold | $25.00 | +24.50% | Downgrades | 21 days ago |
Tyra Biosciences IncTYRA | 3 | Buy | $45.00 | +56.85% | Reiterates | 22 days ago |
Avalo Therapeutics IncAVTX | 4 | Buy | $35.00 | +154.73% | Maintains | 22 days ago |
Intellia Therapeutics IncNTLA | 8 | Buy | $25.00 | +92.01% | Maintains | 23 days ago |
Cartesian Therapeutics IncRNAC | 2 | Buy | $25.00 | +299.04% | Maintains | 24 days ago |
Cytomx Therapeutics IncCTMX | 3 | Buy | $11.00 | +241.61% | Maintains | 25 days ago |
Generate Biomedicines IncGENB | 2 | Buy | $25.00 | +93.65% | Maintains | a month ago |
Summit Therapeutics IncSMMT | 9 | Buy | $23.00 | +52.62% | Maintains | a month ago |
Halozyme Therapeutics IncHALO | 6 | Buy | $95.00 | +36.06% | Maintains | a month ago |
Century Therapeutics IncIPSC | 1 | Buy | $5.00 | +141.55% | Maintains | a month ago |
Sarepta Therapeutics IncSRPT | 5 | Sell | $5.00 | -69.21% | Reiterates | 2 months ago |
Palisade Bio IncPALI | 1 | Buy | $7.00 | +262.69% | Initiates Coverage On | 2 months ago |
Crescent Biopharma IncCBIO | 3 | Buy | $22.00 | +22.36% | Maintains | 3 months ago |
Neurogene IncNGNE | 4 | Buy | $70.00 | +166.97% | Reiterates | 5 months ago |
Lexeo Therapeutics IncLXEO | 4 | Buy | $10.00 | +122.22% | Maintains | 5 months ago |
Meiragtx Holdings PLCMGTX | 1 | Buy | $20.00 | +112.99% | Initiates Coverage On | 6 months ago |
Crispr Therapeutics AgCRSP | 1 | Buy | $80.00 | +53.61% | Reiterates | 8 months ago |
Instil Bio IncTIL | 3 | Buy | $125.00 | +1,418.83% | Reiterates | 9 months ago |
Editas Medicine IncEDIT | 2 | Buy | $5.00 | +79.86% | Reiterates | 9 months ago |
Metagenomi Therapeutics IncMGX | 1 | Buy | $7.00 | +426.32% | Reiterates | 10 months ago |
Zura Bio LtdZURA | 1 | Hold | $2.00 | -48.19% | Maintains | 10 months ago |
Boundless Bio IncBOLD | 1 | Buy | $4.00 | +177.78% | Maintains | 10 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.